Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy

Published:2024 Issue: Volume: Page:509-524
ISSN:
Container-title:Manual of Hematopoietic Cell Transplantation and Cellular Therapies
language:
Short-container-title:

Author:

Greenbaum URI,Ramdial JEREMY L.,Afrough AIMAZ,Alsfeld LEONARD C.,Ghanem SASSINE,Daher MAY,Olson AMANDA,Kebriaei PARTOW,Strati PAOLO,Steiner RAPHAEL E.,Ahmed SAIRAH,Tanner MARK R.,Neelapu SATTVA S.,Rezvani KATAYOUN,Shpall ELIZABETH J.

Publisher

Elsevier

Reference82 articles.

1. Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

2. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

3. Axicabtagene ciloleucel car t-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

4. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial;Locke;Lancet Oncol,2019

5. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study;Abramson;Lancet,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP